Dr. Carol Routledge is the Director of Research at Alzheimer’s Research UK where she currently drives the research agenda. Carol moved to the charity in 2017 from the Dementia Discovery Fund, where she was a Venture Partner with a key focus on identifying and developing novel disease-modifying mechanisms for the treatment of all types of dementia, sourcing opportunities from academic research groups and small companies.
She has had a successful career with a number of UK and US based major pharmaceutical and biotechnology companies, with leadership roles in drug acquisition and translational medicine strategies, with a focus on neuroscience. A combination of preclinical and clinical experience gives her the advantage of being able to apply a strong scientific rationale and innovative experimental approaches to clinical development. Carol has a PhD in neuropharmacology from Queens Medical School in Nottingham.